Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Sarda Proteins Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Sarda Proteins şirketinin toplam hissedar öz sermayesi ₹23.7M ve toplam borcu ₹0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹24.3M ve ₹618.9K dir.

Anahtar bilgiler

Borç/özkaynak oranı

₹0

Borç

Faiz karşılama oranı	n/a
Nakit	₹1.19m
Eşitlik	₹23.73m
Toplam yükümlülükler	₹618.94k
Toplam varlıklar	₹24.35m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 519242 'nin kısa vadeli varlıkları ( ₹23.0M ) kısa vadeli yükümlülüklerini ( ₹184.5K ) aşıyor.

Uzun Vadeli Yükümlülükler: 519242 şirketinin kısa vadeli varlıkları ( ₹23.0M ) uzun vadeli yükümlülüklerini ( ₹434.5K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 519242 borçsuzdur.

Borcun Azaltılması: 519242 şirketinin 5 yıl önce borç/öz sermaye oranı 0.4% iken borcu yok.

Borç Kapsamı: 519242 un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: 519242 şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Sarda Proteins Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Sarda Proteins Ltd, Annual General Meeting, Sep 28, 2024

First quarter 2025 earnings released: ₹0.46 loss per share (vs ₹0.01 loss in 1Q 2024)

Sarda Proteins Ltd Announces Resignation of Mahavir Pratap Sharma as Independent Director, Effective August 11, 2024

Sarda Proteins Ltd Receives Resignation from Amit Kumar Modi as Company Secretary & Compliance Officer

Sarda Proteins Ltd Approves Board Changes

Sarda Proteins Ltd Announces Resignation of Shipra Gandhi as Chief Financial Officer

Sarda Proteins Ltd Appoints Khilan Hareshbhai Savaliya as Additional Director (Non-Executive)

Sarda Proteins Ltd Appoints Khilan Hareshbhai Savaliya as Additional Director (Non-Executive)

Less than half of directors are independent

Sarda Proteins Ltd Appoints Chirag Shantilal Thumar as Additional Executive Director

Sarda Proteins Ltd Appoints Chirag Shantilal Thumar as Additional Executive Director

MD & Director recently sold ₹3.0m worth of stock

Full year 2024 earnings released: EPS: ₹0.11 (vs ₹0.19 loss in FY 2023)

Sarda Proteins Ltd to Report Q4, 2024 Results on Apr 30, 2024

Sarda Proteins Ltd to Report Q4, 2024 Results on Apr 30, 2024

Insufficient new directors

Third quarter 2024 earnings released: EPS: ₹0.04 (vs ₹0.01 in 3Q 2023)

Sarda Proteins Ltd to Report Q3, 2024 Results on Feb 13, 2024

Sarda Proteins Ltd Announces Resignation of Somya Data as Chief Financial Officer

Second quarter 2024 earnings released: ₹0.03 loss per share (vs ₹0.02 profit in 2Q 2023)

Sarda Proteins Ltd to Report Q2, 2024 Results on Nov 07, 2023

Sarda Proteins Ltd, Annual General Meeting, Sep 29, 2023

Sarda Proteins Ltd to Report Q1, 2024 Results on Aug 14, 2023

New major risk - Share price stability

Full year 2023 earnings released: ₹0.19 loss per share (vs ₹1.78 profit in FY 2022)

Sarda Proteins Ltd to Report Q4, 2023 Results on May 30, 2023

Investor sentiment improves as stock rises 15%

Investor sentiment deteriorates as stock falls 16%

Insufficient new directors

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.32 in 3Q 2022)

Sarda Proteins Ltd Announces Chief Financial Officer Changes

Sarda Proteins Ltd to Report Q3, 2023 Results on Jan 30, 2023

Sarda Proteins Ltd Announces Resignation of Himanshu Gupta as Chief Financial Officer, Effective 30 January 2023

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Second quarter 2023 earnings released: EPS: ₹0.02 (vs ₹0.14 loss in 2Q 2022)

Sarda Proteins Ltd to Report Q2, 2023 Results on Oct 19, 2022

Investor sentiment improved over the past week

Sarda Proteins Limited, Annual General Meeting, Sep 23, 2022

Investor sentiment improved over the past week

Sarda Proteins Limited to Report Q1, 2023 Results on Aug 05, 2022

Investor sentiment improved over the past week

Sarda Proteins Limited to Report Q4, 2022 Results on May 27, 2022

High number of new and inexperienced directors

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new and inexperienced directors

Full year 2021 earnings released: ₹0.12 loss per share (vs ₹0.19 profit in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: ₹0.17 loss per share (vs ₹0.56 profit in 3Q 2020)

Sarda Proteins Ltd. to Report Q3, 2021 Results on Feb 12, 2021

Market bids up stock over the past week

Sarda Proteins Ltd. to Report Q2, 2021 Results on Nov 09, 2020

Sarda Proteins Ltd. to Report Q2, 2020 Results on Sep 02, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin